Clinical trial Recruiting at 1 site Observational Ages 18 and up

Registry of cataract surgery outcomes after phacoemulsification with different intraocular lenses.

Official title: Phacoemulsification and Intraocular Lens Implantation: Patient Registry

Run by Sensor Cliniq · NCT07276217 · Data updated 2026-11-12

This project will collect data to see how people who have phacoemulsification do with different types of intraocular lenses.

More Cataract trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorSensor Cliniq
Academic / other
Locations1 site (Warsaw)
StatusRecruiting
StartedJanuary 2, 2025
Main results expectedJuly 2026
Study endsJuly 2026
Registry record updatedDecember 10, 2025
Trial IDNCT07276217 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Patients who have had or are scheduled for bilateral cataract surgery with implantation of an EDOF, monofocal-plus, or standard monofocal intraocular lens are eligible.

Probably not a fit

Patients with significant anterior or posterior segment disease (for example severe dry eye, corneal dystrophy, uveitis, retinal degeneration, glaucoma, or diabetic retinopathy), pseudoexfoliation, keratoconus, prior laser refractive or other ocular surgery (except cataract), amblyopia, posterior capsule opacification, postoperative BCVA < 0.5, or intraoperative complications are excluded and therefore unlikely to benefit from this registry.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry will compile retrospective and prospective clinical data on patients undergoing phacoemulsification with implantation of EDOF, monofocal-plus, or standard monofocal intraocular lenses. Retrospective data will include routinely collected preoperative, intraoperative, and postoperative information, while prospective follow-up will capture visual acuity, refraction, exam findings, patient-reported outcomes, and complications. Patients will be followed for up to 60 months after surgery to compare outcomes across lens types and time points. The registry aims to enable real-world comparisons of safety, visual performance, and patient experience associated with different IOL technologies.

Why it matters

Potential benefit: If successful, the registry could help surgeons and patients choose the intraocular lens type most likely to give better vision and fewer complications.

How similar studies have gone: Comparable registries and comparative studies of intraocular lens types have provided useful information, though long-term comparative data for newer EDOF and monofocal-plus lenses remain somewhat limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients who have undergone cataract surgery or are scheduled for bilateral cataract surgery with implantation of an extended-depth-of-focus (EDOF) intraocular lens, a monofocal-plus intraocular lens, or a standard monofocal intraocular lens.

Exclusion Criteria:

* Anterior or posterior segment pathologies affecting postoperative visual acuity, including but not limited to: severe dry eye syndrome, corneal dystrophies, uveitis, retinal degenerative changes, glaucoma, or diabetic retinopathy.
* Pseudoexfoliation syndrome
* Keratoconus
* History of laser refractive surgery
* Prior ocular surgery other than cataract surgery
* Amblyopia
* Posterior capsule opacification
* Postoperative best-corrected visual acuity (BCVA) less 0.5
* Intraoperative complications, including posterior capsule rupture

Where it's running

  • Sensor Cliniq
    Warsaw, Poland
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.